1-7 of 7
Christine Dehner
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Two-year follow-up of lisocabtagene maraleucel in relapsed or refractory large B-cell lymphoma in TRANSCEND NHL 001

Clinical Trials & Observations
Jeremy S. Abramson, M. Lia Palomba, Leo I. Gordon, Matthew Lunning, Michael Wang, Jon Arnason, Enkhtsetseg Purev, David G. Maloney, Charalambos Andreadis, Alison Sehgal, Scott R. Solomon, Nilanjan Ghosh, Christine Dehner, Yeonhee Kim, Ken Ogasawara, Ana Kostic, Tanya Siddiqi
Journal: Blood
Blood (2024) 143 (5): 404–416.
https://doi.org/10.1182/blood.2023020854
Published: 2024
Includes: Supplemental data
Journal Articles

Two-Year Follow-up of Transcend NHL 001, a Multicenter Phase 1 Study of Lisocabtagene Maraleucel (liso-cel) in Relapsed or Refractory (R/R) Large B-Cell Lymphomas (LBCL)

Jeremy S. Abramson, M. Lia Palomba, Leo I. Gordon, Matthew A. Lunning, Michael Wang, Jon E. Arnason, Enkhtsetseg Purev, David G. Maloney, Charalambos Andreadis, Alison R. Sehgal, Scott R. Solomon, Nilanjan Ghosh, Ana Kostic, Yeonhee Kim, Ken Ogasawara, Christine Dehner, Tanya Siddiqi
Journal: Blood
Blood (2021) 138 (Supplement 1): 2840.
https://doi.org/10.1182/blood-2021-148948
Published: 2021
Journal Articles

Safety and Preliminary Efficacy in Patients with Relapsed/Refractory Mantle Cell Lymphoma Receiving Lisocabtagene Maraleucel in Transcend NHL 001

Maria Lia Palomba, MD, Leo I. Gordon, MD, Tanya Siddiqi, MD, Jeremy S. Abramson, MD, Manali Kamdar, MD, Matthew A. Lunning, DO, FACP, David G. Maloney, MD PhD, Charalambos Andreadis, MD MSCE, Jon E. Arnason, MD, Nilanjan Ghosh, MD PhD, Amitkumar Mehta, MD, Scott R. Solomon, MD, Thalia Farazi, MD PhD, Jacob Garcia, MD, Christine Dehner, BSc, Ken Ogasawara, PhD MPH, Jie Gao, PhD, Michael Wang, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–11.
https://doi.org/10.1182/blood-2020-136158
Published: 2020
Journal Articles

Impact of Lisocabtagene Maraleucel (liso-cel) Treatment on Health-Related Quality of Life and Health Utility in Patients (pts) with Relapsed/Refractory (R/R) Aggressive B Cell Non-Hodgkin Lymphoma (NHL): Transcend NHL 001

Donald L. Patrick, Annette Powers, Monika Parisi, Yeonhee Kim, Jacob Garcia, MD, Christine Dehner, David G. Maloney, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 66.
https://doi.org/10.1182/blood-2019-127145
Published: 2019
Journal Articles

Estimation of the Resource Utilization and Costs of Cytokine Release Syndrome Observed in the Transcend-NHL Clinical Trial: A Micro-Costing Study

Tanya Siddiqi, MD, Jacob Garcia, MD, Christine Dehner, Andy Nguyen, PhD, Matthew Gitlin, PharmD, Karen C. Chung, PharmD, MS, Jeremy S. Abramson, MD MMSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 319.
https://doi.org/10.1182/blood-2018-99-112214
Published: 2018
Journal Articles

TRANSCEND: Lisocabtagene Maraleucel (liso-cel; JCAR017) Healthcare Resource Utilization in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

M. Lia Palomba, MD, Jacob Garcia, MD, Lei Wang, PhD, Christine Dehner, Karen C. Chung, PharmD, MS, David G. Maloney, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3545.
https://doi.org/10.1182/blood-2018-99-119387
Published: 2018
Journal Articles

Treatment with AMD3100 in Multiple Myeloma or Non-Hodgkin’s Lymphoma Patients to Increase the Number of Peripheral Blood Stem Cells When Given with a Mobilizing Regimen of Chemotherapy and G-CSF.

Michael J. Dugan, MD, Luke P. Akard, MD, James M. Thompson, DO, Auayporn Nademanee, MD, Richard T. Maziarz, MD, William I. Bensinger, MD, Jane Liesveld, MD, Karin Badel, Christine Dehner, Colleen Gibney, Gary Calandra, Jan Jansen, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 2860.
https://doi.org/10.1182/blood.V104.11.2860.2860
Published: 2004